Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-Oesophageal Junction Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07431281
What this trial is testing

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaEsophageal Cancer
AstraZeneca 2,130
Testing effectiveness (Phase 2)Looking for participantsNCT05033392
What this trial is testing

PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer

Who this might be right for
Stomach Neoplasms
Wan He 62
Testing effectiveness (Phase 2)UnknownNCT01747707
What this trial is testing

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Chinese Academy of Medical Sciences 40
Large-scale testing (Phase 3)Ended earlyNCT01641939
What this trial is testing

Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 415
Early research (Phase 1)UnknownNCT04460456
What this trial is testing

SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Who this might be right for
HER2 Positive Solid Tumors
Silverback Therapeutics 58
Testing effectiveness (Phase 2)WithdrawnNCT02274012
What this trial is testing

Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Who this might be right for
HER-2 Positive Gastric CancerGastrooesophageal CancerEsophageal Cancer
Columbia University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03488667
What this trial is testing

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

Who this might be right for
Gastro Esophageal Junction CancerStomach CancerAdenocarcinoma
University of Kansas Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT02287129
What this trial is testing

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Esophagogastric Junction
Technical University of Munich 75
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05476796
What this trial is testing

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

Who this might be right for
Gastric AdenocarcinomaEsophagus AdenocarcinomaGastroesophageal Junction Adenocarcinoma
UNICANCER 118
Early research (Phase 1)Ended earlyNCT02283359
What this trial is testing

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 3
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Not applicableUnknownNCT05620524
What this trial is testing

Therapeutic Oncolytic Monitoring as a Tool for Effective Exposure to 5-FU in Patients With Locally Advanced, Resectable Gastric or Gastro-oesophageal Junction Cancer Treated With Perioperative FLOT

Who this might be right for
TDM of 5-FUPharmacokinetic Observational Study
Catharina Ziekenhuis Eindhoven 20
Testing effectiveness (Phase 2)Ended earlyNCT02202759
What this trial is testing

MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the StomachGastroesophageal Junction Expressing Guanylyl Cyclase C
Millennium Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT02082210
What this trial is testing

Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Who this might be right for
Advanced CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+3 more
Eli Lilly and Company 97
Testing effectiveness (Phase 2)Study completedNCT00858338
What this trial is testing

Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer

Who this might be right for
Gastric CancerStomach Cancer
NYU Langone Health 28
Large-scale testing (Phase 3)Study completedNCT04082364
What this trial is testing

Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerHER2-positive Gastric Cancer
MacroGenics 82
Large-scale testing (Phase 3)Ended earlyNCT05111626
What this trial is testing

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Amgen 515
Not applicableNot Yet RecruitingNCT07625735
What this trial is testing

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction AdenocarcinomaMismatch Repair Deficient or MSI-High Solid TumorsLymph Node Metastasis+1 more
Shanghai Zhongshan Hospital 3,000
Testing effectiveness (Phase 2)UnknownNCT06046963
What this trial is testing

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerPeritoneal MetastasesAscites, Malignant
Zhejiang Cancer Hospital 35
Next Page